T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Biogen
BIIB
$31B
| $135M | 0.01% |
965,457
+131,530
| +16% | +$17.8M |
|
552
Commault Systems
CVLT
$6.02B
| $134M | 0.01% |
711,764
+211,944
| +42% | +$38.2M |
|
553
Estee Lauder
EL
$32B
| $133M | 0.01% |
1,513,092
+1,172,431
| +344% | +$104M |
|
554
Royal Gold
RGLD
$19.3B
| $133M | 0.01% |
663,853
+237,640
| +56% | +$41.1M |
|
555
Birkenstock
BIRK
$7.87B
| $132M | 0.01% |
2,924,795
+2,782,873
| +1,961% | +$136M |
|
556
Alamos Gold
AGI
$13.7B
| $132M | 0.01% |
3,791,527
-915,772
| -19% | -$26.2M |
|
557
IQVIA
IQV
$40.2B
| $132M | 0.01% |
694,937
+449,920
| +184% | +$81.8M |
|
558
Dycom Industries
DY
$12.3B
| $131M | 0.01% |
448,454
+296,927
| +196% | +$77.9M |
|
559
Mattel
MAT
$4.25B
| $131M | 0.01% |
7,756,736
-1,041,538
| -12% | -$19M |
|
560
Tapestry
TPR
$26.1B
| $130M | 0.01% |
1,152,309
+853,124
| +285% | +$89.3M |
|
561
Cytokinetics
CYTK
$10.5B
| $130M | 0.01% |
2,366,848
+500,871
| +27% | +$20.6M |
|
562
Workiva
WK
$3.73B
| $128M | 0.01% |
1,491,423
+1,442,129
| +2,926% | +$108M |
|
563
BWX Technologies
BWXT
$15.6B
| $128M | 0.01% |
695,239
+413,661
| +147% | +$66.6M |
|
564
DexCom
DXCM
$34.4B
| $128M | 0.01% |
1,898,045
+149,640
| +9% | +$11.8M |
|
565
General Dynamics
GD
$106B
| $127M | 0.01% |
371,962
+2,002
| +0.5% | +$631K |
|
566
MSCI
MSCI
$41B
| $127M | 0.01% |
223,112
-37,730
| -14% | -$21.3M |
|
567
Reddit
RDDT
$29.9B
| $126M | 0.01% |
548,852
+175,532
| +47% | +$35.8M |
|
568
United Therapeutics
UTHR
$21.7B
| $126M | 0.01% |
300,931
+186,429
| +163% | +$62.7M |
|
569
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.62B
| $126M | 0.01% |
953,455
| – | – |
|
570
Axsome Therapeutics
AXSM
$11.3B
| $126M | 0.01% |
1,037,448
+424,705
| +69% | +$47.8M |
|
571
Unilever
UL
$135B
| $126M | 0.01% |
1,889,213
+955,331
| +102% | +$65.9M |
|
572
Flutter Entertainment
FLUT
$17.2B
| $125M | 0.01% |
491,839
+61,836
| +14% | +$18.1M |
|
573
HF Sinclair
DINO
$15.6B
| $125M | 0.01% |
2,381,335
+306,826
| +15% | +$14.5M |
|
574
Global E Online
GLBE
$7.05B
| $125M | 0.01% |
+3,485,099
| New | +$119M |
|
575
Louisiana-Pacific
LPX
$5.26B
| $124M | 0.01% |
1,391,030
+444,888
| +47% | +$41.1M |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.